Prognostic Impact of the Neutrophil/Lymphocyte Ratio (NLR) in the Treatment of First-line Metastatic or Locally Advanced Breast Cancer Treated With CDK4/6 Inhibitor.
Clinical trial NCT05303129 · COMPLETED
Trial details
- NCT number
- NCT05303129
- Sponsor
- Centre Francois Baclesse
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-27
- Primary completion
- 2024-12-17
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.